Serving Orphan-to-Large "Nested" Markets Psyncretis, Inc. (sin-CRET-is) is a privately owned company for research and development of pharmaceuticals and biologics for "nested" markets -- biochemically-related neurologic, physiologic or infectious diseases spanning small (orphan) to large populations...

President and Chief Scientific Officer Management and Scientific Advisors Clinician Network and Consultants Intellectual Property and Legal Consultant Administrative and Financial Consultant President and Chief Scientific Officer Frank H. Burton, Ph.D. Dr. Burton is also company Founder. To maintain...

Serving Orphan-to-Large "Nested" Markets Psyncretis, Inc. (sin-CRET-is) is a privately owned company for research and development of pharmaceuticals and biologics for "nested" markets -- biochemically-related neurologic, physiologic or infectious diseases spanning small (orphan) to large populations...

Academic-to-Basic Pipeline and Preclinical-to-Clinical Expertise Our R&D platform includes: The transgenic "Ticcy" mouse --- the first and only current drug response-predictive preclinical animal model of tics, compulsions and trichotillomania, suitable for rapid-throughput screening of prospe...